Also worth noting that the study was in a rather particular cell line that may not be reflective of the average person:
> According to the web site huh7.com, it is "a well differentiated hepatocyte-derived carcinoma cell line, originally taken from a liver tumor in a 57-year-old Japanese male in 1982."
> At this stage, we do not know if DNA reverse transcribed from BNT162b2 is integrated into the cell genome.